Beacon Biomedical

Beacon Biomedical Inc is a molecular proteomic diagnostics company focused on developing and commercializing both CLIA laboratory and point-of-care CLIA waived tests for earlier cancer detection. The company’s lead product, BeScreened™-CRC, is a blood-based test for the early detection of colorectal cancer. Beacon’s product development pipeline includes early detection assays for breast, lung, prostate and ovarian cancers. For more information visit, www.beaconbiomedical.com Cancer Detection made easy, accurate and affordable...Welcome to the Beacon Revolution!